SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs rally to fresh highs is drawing attention after bullish analyst upgrades tied to growth in sovereign AI and customized software. Bulls are celebrating the breakout and speculating about a squeeze, while bears argue the valuation is stretched and warn of a pullback.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Nasdaq-100 reentry and expected index-fund buying, alongside optimism about an NIH-backed cancer-vaccine initiative and its Merck-partnered melanoma-vaccine results, are driving attention. Bulls point to pipeline potential and momentum, while skeptics argue the rally has outpaced the companys fundamentals and could give way to profit-taking.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is drawing attention after the lockup expiration made previously restricted shares tradable, with traders debating whether added supply and a premium-to-NAV valuation are driving the sharp volatility. Bulls still frame the fund as a way to gain exposure to Anthropic ahead of a potential IPO, while bears focus on dilution, selling pressure, and whether the funds reported NAV supports its market price.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

DOTs sharp rebound from recent lows is driving attention, with traders debating whether it marks a durable recovery or a short-lived bounce in a token still far below past highs. Bullish posts point to Polkadot upgrades and tokenomics changes, while skeptics emphasize weak demand and the prolonged downtrend.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY is drawing attention for its variable weekly distributions and price swings tied to MicroStrategy and Bitcoin. Bulls welcome the income and potential recovery if BTC and MSTR strengthen, while skeptics point to falling payouts and NAV erosion.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two is drawing attention ahead of the anticipated November release of Grand Theft Auto VI, with traders betting on blockbuster sales and a pre-launch rebound. That optimism is tempered by persistent share-price weakness and concerns that the games online mode may arrive later, leaving investors debating whether the launch hype is already priced in.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Tight diesel supply and unusually strong refining crack spreads amid energy-market disruptions are driving attention to Valero and other refiners. Traders remain divided between the strong margin backdrop and concerns about profit-taking, stretched valuations, and possible diesel export restrictions that could alter refining economics.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs planned acquisition of Grain Managements 800 MHz spectrum portfolio has intensified concerns that Starlink Mobile could eventually compete with T-Mobile and other U.S. carriers, contributing to a sharp TMUS selloff. Traders are divided between viewing the deal as a long-term competitive threat and calling the market reaction excessive, arguing that building a viable terrestrial network would take substantial time and investment.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

Reports that OpenAIs revenue run rate fell short of earlier expectations have fueled concerns about AI demand and the durability of chipmakers growth, weighing on semiconductor stocks and prompting discussion of a rotation into software. Traders are split between viewing the pullback as a warning about AI spending and seeing it as a pause in a still-strong chip-demand trend.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflakes strong quarterly results and raised outlook, attributed to accelerating platform consumption and AI adoption, are driving attention. Bulls view the results as evidence that enterprise AI is boosting demand, while skeptics point to the companys high valuation and lack of GAAP profitability and expect gains to face profit-taking.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EXCLUSIVE: Nvidia GPUs Are EssentialBut They Won't Decide Who Wins AI Drug Discovery, Generate CTO Says

Generate Biomedicines CTO says Nvidia GPUs are essential, but data and experimentation will determine AI drug discovery winners.read more...

QUICK SPARK: Nvidia-Backed Biotech Says AI Could Make Biology Programmable

Generate Biomedicines says AI could make biology programmable by generating and testing drug hypotheses at machine scale.read more...

EXCLUSIVE: Nvidia's Biggest Contribution to AI Drug Discovery Isn't Money, Generate CTO Says

Generate Biomedicines co-founder & CTO says Nvidia's biggest contribution to AI drug discovery is technical collaboration, not just capital.read more...

Nvidia CEO Jensen Huang Said AI's 'Most Profound Impact Will Be in Life Sciences.' Does This Bet on a Biotech Stock Prove He Means It?

Key PointsThe chipmaker has active interests in the healthcare market, including a partnership with Eli Lilly and an investment in small biotech Generate Biomedicines...

Cathie Wood Likes That New Stock Smell: 3 IPO Stocks She Bought on Monday

Key PointsCathie Wood added to her positions in Space Exploration, Bullish, and Generate Biomedicines on Monday...

AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts

AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts PR Newswire BOSTON, June 22, 2026 Newly Constructed Phase 2 now 100...

A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer

Key PointsHarbourVest initiated 1,722,210 shares of Generate Biomedicines last quarter; the estimated trade size was $21.03 million based on quarterly average prices...

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire SOMERVILLE, Mass., May 28, 2026 SOMERVILLE, Mass., May 28, 2026 /PRNewswire...

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update PR Newswire SOMERVILLE, Mass., May 7, 2026 SOLAIRIA-1 AND SOLAIRIA-2 Phase 3 clinical trials...

Generate Biomedicines (NASDAQ:GENB) Hits New 1-Year High  - Should You Buy?

Generate Biomedicines (NASDAQ:GENB) Reaches New 52-Week High - Time to Buy...

Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.

Generate Biomedicines Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$14.34
Prev Close	$13.99
Open	$14.06
Dividend Yield	N/A
50-Day Moving Average	$15.51
Beta	0.95
Avg. Volume	1.16M
PE Ratio	N/A

52-Week High	$22.67
52-Week Low	$11.00
Market Capitalization	$1.8B
EPS (Annual)	-$1.96
Price to Book	3.93
Revenue Per Employee	$102,221.15

Feed

News

Sentiment

Earnings

Fundamentals

Info

GENB Fundamentals